{"id":"W4394996970","doi":"10.1007/s00415-024-12326-z","title":"ENSEMBLE PLUS: final results of shorter ocrelizumab infusion from a randomized controlled trial","year":2024,"lang":"en","type":"article","venue":"Journal of Neurology","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":true,"ca_institutions":"Ottawa Hospital; University of Ottawa","funders":"F. Hoffmann-La Roche","keywords":"Medicine; Ocrelizumab; Randomization; Tolerability; Clinical endpoint; Anesthesia; Adverse effect; Randomized controlled trial; Volunteer; Surgery; Internal medicine; Rituximab","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.008545094,0.001378626,0.004868085,0.0003685489,0.0003297284,0.001715456,0.000761361,0.001382102,0.008432427],"category_scores_gemma":[0.011971,0.0004284302,0.004568939,0.0004154013,0.0005632484,0.001839852,0.0007724664,0.00211906,0.0004717188],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.000600683,"about_ca_system_score_gemma":0.0008683404,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0004369152,"about_ca_topic_score_gemma":0.001175835,"domain_scores_codex":[0.9956042,0.002900541,0.0004054789,0.0005239899,0.0003440175,0.0002218246],"domain_scores_gemma":[0.9930667,0.00356869,0.001596088,0.000651972,0.0004694098,0.0006472106],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.9590439,0.0006523108,0.001277979,0.00222873,0.01051439,0.00007127544,0.00004752911,0.0005250334,0.0007711466,0.0002614251,0.002126073,0.02248026],"study_design_scores_gemma":[0.942767,0.02646924,0.007960265,0.0003859494,0.01749118,0.0001036739,0.00003839832,0.001097101,0.0003214442,0.0007378394,0.002566674,0.00006126393],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.925268,0.05054631,0.004130886,0.002932252,0.002428638,0.003278241,0.006548773,0.0004166106,0.004450395],"genre_scores_gemma":[0.9690812,0.00905206,0.00622753,0.002994857,0.001731773,0.003911509,0.004509197,0.00008644531,0.002405452],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.008545094,"threshold_uncertainty_score":0.04519135,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.05244302263326506,"score_gpt":0.342308598512043,"score_spread":0.289865575878778,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}